Andrea Botticelli

Pubblicazioni

Titolo Pubblicato in Anno
Molecular detection of EMT markers in circulating tumor cells from metastatic non-small cell lung cancer patients. Potential role in clinical practice ANALYTICAL CELLULAR PATHOLOGY 2018
TK inhibitor pazopanib primes DCs by downregulation of the β-catenin pathway CANCER IMMUNOLOGY RESEARCH 2018
Prognosis of elderly gastric cancer patients after surgery: a nomogram to predict survival MEDICAL ONCOLOGY 2018
The microbiota impact. bacteria shaping immunity, disease and response to therapy TRANSLATIONAL CANCER RESEARCH 2018
The ambitious role of anti angiogenesis molecules: Turning a cold tumor into a hot one CANCER TREATMENT REVIEWS 2018
Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC? JOURNAL OF TRANSLATIONAL MEDICINE 2018
Lean body mass wasting and toxicity in early breast cancer patients receiving anthracyclines ONCOTARGET 2018
Effect of nutritional support with highly purified, whey proteins for malnutrition and sarcopenia in patients affected with stage II-III colorectal or breast cancer: A blind, placebo controlled, randomized clinical trial JOURNAL OF CLINICAL ONCOLOGY 2018
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study CANCER BIOLOGY & THERAPY 2018
Nivolumab in pretreated non-small cell lung cancer: Continuing the immunolution TRANSLATIONAL LUNG CANCER RESEARCH 2018
Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab CANCER BIOLOGY & THERAPY 2018
Biliary tract cancer: current challenges and future prospects CANCER MANAGEMENT AND RESEARCH 2018
Evaluation of 5-fluorouracil degradation rate and pharmacogenetic profiling to predict toxicity following adjuvant capecitabine EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 2017
Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment ONCOTARGET 2017
Pharmacogenetic Approach to Toxicity in Breast Cancer Patients Treated with Taxanes ANTICANCER RESEARCH 2017
A nomogram to predict 5-fluorouracil toxicity: when pharmacogenomics meets the patient ANTI-CANCER DRUGS 2017
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience ONCOTARGET 2017
Fasting glucose and body mass index as predictors of activity in breast cancer patients treated with everolimus-exemestane: the EverExt study SCIENTIFIC REPORTS 2017
PD-L1 expression in TNBC: a predictive biomarker of response to neoadjuvant chemotherapy? BIOMED RESEARCH INTERNATIONAL 2017
The role of stereotactic body radiation therapy in oligometastatic colorectal cancer MEDICINE 2017

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma